Concord Health Invests in NeuroFlow’s Behavioral Health SaaS Platform

What You Should Know:

– Concord Health Partners, a healthcare-focused investment firm, announced their investment in NeuroFlow, the market-leading behavioral health SaaS platform.

– NeuroFlow’s platform combines AI-driven analytics, care collaboration enablement, and enterprise consumer-grade activation to reduce the risks of identifying, managing, and monitoring complex behavioral health and substance use populations.

– Concord’s investment will provide NeuroFlow with capital to continue to grow the company to match the increase in demand for its solutions from hospitals and health systems, as well as within the complex payor and government agency segments.

Extended-Infusion Antibiotics Tied to Reduced Mortality From Bloodstream Infections

Extended infusion of beta-lactam therapy was associated with reduced mortality in patients with severe gram-negative bloodstream infections, according to a retrospective cohort study. At 90

July 5, 2024

World’s first rigid endoscope system for hyperspectral imaging during medical procedures

Hyperspectral imaging (HSI) is a state-of-the-art technique that captures and processes information across a given electromagnetic spectrum.

April 29, 2024

AstraZeneca, Daiichi Sankyo claim PhIII lung cancer win for their next big ADC — but shares fall

AstraZeneca and Daiichi Sankyo’s multibillion-dollar antibody-drug conjugate alliance has generated a Phase III win, the partners say, beefing up the case that they have a

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.